WO2001070978A3 - Polypeptides and nucleic acids encoding same - Google Patents

Polypeptides and nucleic acids encoding same Download PDF

Info

Publication number
WO2001070978A3
WO2001070978A3 PCT/US2001/009093 US0109093W WO0170978A3 WO 2001070978 A3 WO2001070978 A3 WO 2001070978A3 US 0109093 W US0109093 W US 0109093W WO 0170978 A3 WO0170978 A3 WO 0170978A3
Authority
WO
WIPO (PCT)
Prior art keywords
novx
polypeptides
nucleic acids
acids encoding
encoding same
Prior art date
Application number
PCT/US2001/009093
Other languages
French (fr)
Other versions
WO2001070978A2 (en
Inventor
Raymond J Taupier Jr
Kumud Majumder
Steven K Spaderna
Glenda Smithson
Peter S Mezes
Corine A M Vernet
Original Assignee
Curagen Corp
Raymond J Taupier Jr
Kumud Majumder
Steven K Spaderna
Glenda Smithson
Peter S Mezes
Corine A M Vernet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curagen Corp, Raymond J Taupier Jr, Kumud Majumder, Steven K Spaderna, Glenda Smithson, Peter S Mezes, Corine A M Vernet filed Critical Curagen Corp
Priority to EP01918899A priority Critical patent/EP1232266A2/en
Priority to AU45920/01A priority patent/AU4592001A/en
Priority to CA002374073A priority patent/CA2374073A1/en
Priority to JP2001569361A priority patent/JP2003527859A/en
Publication of WO2001070978A2 publication Critical patent/WO2001070978A2/en
Publication of WO2001070978A3 publication Critical patent/WO2001070978A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Abstract

The present invention provides novel isolated NOVX polynucleotides and polypeptides encoded by the NOVX polynucleotides. Also provided are the antibodies that immunospecifically bind to a NOVX polypeptide or any derivative, variant, mutant or fragment of the NOVX polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the NOVX polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states, as well as to other uses.
PCT/US2001/009093 2000-03-20 2001-03-20 Polypeptides and nucleic acids encoding same WO2001070978A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP01918899A EP1232266A2 (en) 2000-03-20 2001-03-20 Polypeptides and nucleic acids encoding same
AU45920/01A AU4592001A (en) 2000-03-20 2001-03-20 Novel polypeptides and nucleic acids encoding same
CA002374073A CA2374073A1 (en) 2000-03-20 2001-03-20 Novel polypeptides and nucleic acids encoding same
JP2001569361A JP2003527859A (en) 2000-03-20 2001-03-20 Novel polypeptide and nucleic acid encoding the same

Applications Claiming Priority (22)

Application Number Priority Date Filing Date Title
US19076800P 2000-03-20 2000-03-20
US19083500P 2000-03-20 2000-03-20
US60/190,835 2000-03-20
US60/190,768 2000-03-20
US19119900P 2000-03-22 2000-03-22
US19097200P 2000-03-22 2000-03-22
US60/191,199 2000-03-22
US60/190,972 2000-03-22
US19194700P 2000-03-24 2000-03-24
US60/191,947 2000-03-24
US19266500P 2000-03-28 2000-03-28
US19266400P 2000-03-28 2000-03-28
US19298400P 2000-03-28 2000-03-28
US19265700P 2000-03-28 2000-03-28
US60/192,657 2000-03-28
US60/192,984 2000-03-28
US60/192,665 2000-03-28
US60/192,664 2000-03-28
US19283600P 2000-03-29 2000-03-29
US60/192,836 2000-03-29
US19384300P 2000-03-31 2000-03-31
US60/193,843 2000-03-31

Publications (2)

Publication Number Publication Date
WO2001070978A2 WO2001070978A2 (en) 2001-09-27
WO2001070978A3 true WO2001070978A3 (en) 2002-06-27

Family

ID=27582713

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/009093 WO2001070978A2 (en) 2000-03-20 2001-03-20 Polypeptides and nucleic acids encoding same

Country Status (5)

Country Link
EP (1) EP1232266A2 (en)
JP (1) JP2003527859A (en)
AU (1) AU4592001A (en)
CA (1) CA2374073A1 (en)
WO (1) WO2001070978A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1232266A2 (en) * 2000-03-20 2002-08-21 Curagen Corporation Polypeptides and nucleic acids encoding same
JP2004509605A (en) * 2000-05-04 2004-04-02 インサイト・ゲノミックス・インコーポレイテッド Protease
US20010051361A1 (en) * 2000-05-15 2001-12-13 Wei Shao Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2001096562A1 (en) * 2000-06-13 2001-12-20 Merck Patent Gmbh Thyrotropin-releasing hormone receptor-like gpcr (gprfwki)
WO2001098340A2 (en) * 2000-06-23 2001-12-27 Bayer Aktiengesellschaft Regulation of human mast cell protease 6-like enzyme
CN1549858A (en) * 2000-11-27 2004-11-24 阿伦纳药品公司 Endogenous and non-endogenous versions of human G protein-coupled receptors
WO2002048358A2 (en) * 2000-12-14 2002-06-20 Bayer Aktiengesellschaft Regulation of human chemokine-like receptor
WO2003027142A1 (en) * 2001-09-21 2003-04-03 Yamanouchi Pharmaceutical Co., Ltd. Novel g protein-coupled receptor
US8516137B2 (en) 2009-11-16 2013-08-20 Microsoft Corporation Managing virtual hard drives as blobs

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5658758A (en) * 1995-03-24 1997-08-19 Human Genome Sciences Inc Polynucleotides encoding cytostatin I
WO1998033818A1 (en) * 1997-01-31 1998-08-06 Incyte Pharmaceuticals, Inc. Human anion channel
WO2001070978A2 (en) * 2000-03-20 2001-09-27 Curagen Corporation Polypeptides and nucleic acids encoding same
WO2002010387A2 (en) * 2000-07-27 2002-02-07 Incyte Genomics, Inc. G-protein coupled receptors

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5658758A (en) * 1995-03-24 1997-08-19 Human Genome Sciences Inc Polynucleotides encoding cytostatin I
WO1998033818A1 (en) * 1997-01-31 1998-08-06 Incyte Pharmaceuticals, Inc. Human anion channel
WO2001070978A2 (en) * 2000-03-20 2001-09-27 Curagen Corporation Polypeptides and nucleic acids encoding same
WO2002010387A2 (en) * 2000-07-27 2002-02-07 Incyte Genomics, Inc. G-protein coupled receptors

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL 22 February 2000 (2000-02-22), ISOGAI, T. ET AL: "Homo sapiens cDNA FLJ10762 fis, clone NT2RP4000008, moderately similar to CHLORINE CHANNEL PROTEIN P64.", XP002182449 *
DATABASE EMBL 25 January 1999 (1999-01-25), ZHAO S. ET AL: "RPCI11-124J23.TV RPCI-11 Homo sapiens genomic clone RPCI-11-124J23, genomic", XP002191227 *
DATABASE EMBL 26 November 1999 (1999-11-26), BIRREN ET AL.: "Homo sapiens clone RP11-30F17, WORKING DRAFT SEQUENCE, 22 unordered pieces.", XP002182312 *
POWER C A ET AL: "Cloning and characterization of human chemokine receptors", TRENDS IN PHARMACOLOGICAL SCIENCES, ELSEVIER TRENDS JOURNAL, CAMBRIDGE, GB, vol. 17, no. 6, 1 June 1996 (1996-06-01), pages 209 - 213, XP004034558, ISSN: 0165-6147 *

Also Published As

Publication number Publication date
JP2003527859A (en) 2003-09-24
WO2001070978A2 (en) 2001-09-27
AU4592001A (en) 2001-10-03
EP1232266A2 (en) 2002-08-21
CA2374073A1 (en) 2001-09-27

Similar Documents

Publication Publication Date Title
WO2001092523A3 (en) Human polynucleotides and polypeptides encoded thereby
WO2000058473A3 (en) Nucleic acids including open reading frames encoding polypeptides; 'orfx'
WO2001007595A3 (en) Novel fibroblast growth factor and nucleic acids encoding same
WO2001036645A3 (en) Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same
WO2004048521A3 (en) Composition and method for treating lupus nephritis
WO2001049729A8 (en) Novex polypeptides, nucleic acids encoding same and their diagnostic and therapeutic use
WO2001090366A3 (en) Human polynucleotides and polypeptides encoded thereby
WO2002066647A3 (en) Type 2 ctokine receptor and nucleic acids encoding same
WO2000053742A3 (en) Polynucleotides and proteins encoded thereby
WO2001074856A3 (en) Wnt-7b-like polypeptides and nucleic acids encoding same
WO2001070978A3 (en) Polypeptides and nucleic acids encoding same
WO2001062928A3 (en) Polypeptides and nucleic acids encoding same
WO2002002625A3 (en) Novel fibroblast growth factors and nucleic acids encoding same
WO2001061009A3 (en) Polypeptides and nucleic acids encoding same
WO2001036638A8 (en) Polypeptides and nucleic acids encoding same
WO2001044473A3 (en) Polypeptides and nucleic acids encoding same
WO2003025147A3 (en) Novel polynucleotides and proteins encoded thereby
WO2001068851A3 (en) Polypeptides and nucleic acids encoding same
WO2000061754A3 (en) Human proteins and polynucleotides encoding them
WO2001032874A3 (en) Polypeptides and nucleic acids encoding same
WO2000070046A3 (en) Secreted polypeptides and corresponding polynucleotides
WO2001023561A3 (en) Novel polynucleotides encoding proteins containing thrombospondin type 1 repeats
WO2003040345A3 (en) Type 2 cytokine receptor and nucleic acids encoding same
WO2001023572A3 (en) Polynucleotides and polypeptides encoded thereby
WO2001061008A3 (en) Polypeptides and nucleic acids encoding same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US US US US US US US US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

ENP Entry into the national phase

Ref document number: 2374073

Country of ref document: CA

Ref country code: CA

Ref document number: 2374073

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 45920/01

Country of ref document: AU

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 569361

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2001918899

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US US US US US US US US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWP Wipo information: published in national office

Ref document number: 2001918899

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2001918899

Country of ref document: EP